Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Techniclone submits IND for malignant glioma

Sep. 30, 1997

Ribi's melanoma vaccine accepted for fast-track review in Canada

Sep. 29, 1997

Betathine available for licensing from Dovetail

Sep. 29, 1997

Novopharm Biotech seeks approval for melanoma vaccine trial

Sep. 17, 1997

PDL grants antibody humanization patent license to NeoRx

Sep. 17, 1997

Biomira reports phase II results for cancer vaccine

Sep. 15, 1997

New clinical study on Multikine initiated in Canada

Sep. 12, 1997

Regressin induces apoptosis and direct inhibition of tumor cell growth

Sep. 12, 1997

Safety study of Multikine in prostate cancer patients completed

Sep. 10, 1997

Ribi seeks approval for melanoma vaccine in Canada

Sep. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...